United States
The United States leads the multiplex assays market due to its advanced healthcare infrastructure and significant investment in research and development. The growing need for precise diagnostic tools in disease detection, especially for cancer, autoimmune disorders, and infectious diseases, drives the market. Additionally, government funding and public awareness about early...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian